Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Korea, and the Activity of Antimicrobial Combinations against the Isolates
- Document Type
- Publications · Journal Article
- Registered DB
- KCISCIEScopus
- Journal Ranking
- JCR Q2Scopus Q3
- Journal
- JOURNAL OF KOREAN MEDICAL SCIENCE28(1) · pp.62 · 2013
- Citation
- Web of Science 50KCI 3
- JCR IF
- JCR 2012 1.249
- ISSN
- 1011-8934
Authors
- 정혜선이화여자대학교
- 홍성근Corresponding author차의과학대학교
- 김영리제주대학교
- 신경섭충북대학교
- 황동희인제대학교
- 안지영순천향대학교
- 박연준가톨릭대학교
- 어영연세대학교
- Chang, Chulhun Ludgerus부산대학교
- 신종희전남대학교
- 이혜수전북대학교
- 이경원연세대학교
- Yunsop Chong연세대학교
Abstract
The aim of this study was to determine antimicrobial susceptibility of recent clinical Stenotrophomonas maltophilia isolates from Korea, and to compare the activity levels of several combinations of antimicrobials. A total of 206 non-duplicate clinical isolates of S. maltophilia was collected in 2010 from 11 university hospitals. Antimicrobial susceptibility testing was performed using the Clinical Laboratory Standards Institute agar dilution method. In vitro activity of antimicrobial combinations was tested using the checkerboard method. The susceptibility rates to trimethoprim-sulfamethoxazole and minocycline were 96% and 99%, respectively. The susceptibility rate to levofloxacin was 64%. All of four antimicrobial combinations showed synergy against many S. maltophilia isolates. A combination of trimethoprim-sulfamethoxazole plus ticarcillin-clavulanate was most synergistic among the combinations. None of the combinations showed antagonistic activity. Therefore, some of the combinations may be more useful than individual drugs in the treatment of S. maltophilia infection. Further clinical studies are warranted to validate our in vitro test results.
Keywords
Stenotrophomonas maltophiliaCombination Drug TherapyTrimethoprim-SulfamethoxazoleTicarcillin-ClavulanateMULTIPLE ANTIBIOTIC-RESISTANCEIN-VITRO ACTIVITIESXANTHOMONAS-MALTOPHILIASURVEILLANCE PROGRAMCLINICAL STRAINSCYSTIC-FIBROSISTIGECYCLINEPATHOGENSYNERGYMULTICENTER
Identifiers
- WoS UID
- 000314527100009
- KCI
- ART001737195



Login
Back to Publication list